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Abstract 
Background: To evaluate the postoperative results and efficacy of retinectomy in the treatment of severe prolifera-
tive vitreoretinopathy (PVR).
Methods: The study involved 38 individuals with rhegmatogenous retinal detachment initially diagnosed with PVR 
grade C3 who had undergone pars plana vitrectomy combined with scleral buckle and silicone oil as a tamponade. 
A standard three-port pars plana vitrectomy was performed, and the extension of performing a retinectomy was 
decided during the procedure. The patients were followed for a minimum of 6 months after the last surgical pro-
cedure. Reoperation, postoperative hypotony and final reattachment rates were evaluated. Statistical analysis was 
performed with an Exact Fisher’s test.
Results: The mean preoperative visual acuity was >1.3 logMAR. The postoperative visual acuity improved and ranged 
from 1.3 to 0.7 logMAR (p < 0.63). The preoperative intraocular pressure was 10.2 mmHg and postoperatively was 
11.6 mmHg. Postoperative hypotony was observed in 15.8 % of the cases. The reoperation rate after the first proce-
dure was 63.2 %. A total of 44.7 % of the patients needed a retinectomy greater than 270° for a final anatomical suc-
cess. The final retinal reattachment rate was 94.7 %.
Conclusions: Retinectomy can be an effective surgical procedure in the treatment of severe PVR, and it may increase 
the final reattachment rate.
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Background
Proliferative vitreoretinopathy (PVR) is the most com-
mon cause of failure in the management of rhegmatog-
enous retinal detachment (RRD). PVR occurs in 5–10 % 
of retinal detachment (RD) surgeries, and it comprises 
glial and retinal pigment epithelium cells that migrate 
and generate membranes usually on the lower retina as 
a result of gravity. Contraction of these membranes can 
cause new retinal tears, macular pucker, recurrent RD 
and hypotony. PVR categories are grades A, B, and C1–
C5 [1–3].
The rate of anatomic success in RRD surgery can reach 
80–90  % due to current advanced surgical techniques, 
especially in cases of RD involving mild PVR (grades A–
C1). However, in cases of severe PVR (grades C2–C5), 
the prognosis is significantly poorer, considering anatom-
ical and visual outcomes [1–4].
In the past, there has been controversy regarding the 
use of silicone oil versus gas as a tamponade in cases 
of RD associated with severe PVR. The Silicone Study 
(1992) concluded that perfluoropropane (C3F8) or sili-
cone oil is more effective than SF6 in the treatment of 
PVR cases [5]. The use of pharmacological agents as 
adjuvant therapy in RD surgery has been described. 
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Studies have described the use of daunomycin, 5-fluor-
ouacil and heparin as adjuvant therapy. However, these 
studies reported that these drugs failed to improve final 
anatomic results [2, 6, 7].
In 1979, Machemer first described retinectomy as 
a treatment for complex RRD. Since that study, many 
authors have reported relaxing retinectomy as a valuable 
technique in the surgical management of severe PVR to 
achieve a high rate of anatomical success. Additionally, 
recent studies have suggested silicone oil as a superior 
tamponade compared to gas in eyes with PVR [4, 8].
Our study aimed to evaluate the efficacy of retinectomy 
in the surgical treatment of RRD associated with severe 
PVR and its effect on the reoperation rate and final reti-
nal reattachment.
Methods
A retrospective study was conducted in 38 eyes of 38 
patients with RRD initially diagnosed with PVR grade C3 
who had undergone pars plana vitrectomy (PPV) com-
bined with scleral buckle and silicone oil as a tamponade 
from June 2006 to June 2010. The study excluded eyes 
with previous vitrectomy for RRD, non-RRD and trauma.
The surgical technique included 360° peritomy, scleral 
buckle, and three-port incision (scleretomies) combined 
with a 23-gauge vitrectomy, which was performed by one 
experienced retinal surgeon (AG). Retinectomy extension 
was performed according to the surgeon’s decision at the 
time of surgery based on retinal shortening (180°, 270° or 
360°). For all cases, 5000 centistokes silicone oil was used 
as a tamponade and a scleral buckle was not placed if a 
360° shortening was made necessary during vitrectomy.
The postoperative follow-up was performed at 1  day, 
1 week, 15, 30, 60, 90 and 6 months after the last surgi-
cal procedure was performed. Postoperative hypotony 
was defined as intraocular pressure ranging from 0 to 
5 mmHg. Patients who did not complete 6 months of fol-
low-up were excluded. Silicone oil was removed after a 
minimum of 3 months in patients with no signs of recur-
rent PVR or persistent RD.
A Fisher’s test was used to verify the association 
between the rate of reoperation and retinectomy per-
formed. The postoperative average best-corrected vis-
ual acuity (BCVA) was analyzed with a Mann–Whitney 
test because of non-measurable values in LogMAR. A p 
value <0.05 was considered statistically significant.
Results
Patients were 62.9 ±  15.3  years of age and 52.5  % were 
male. Regarding lens status, 78.9 % of patients were pha-
kic, 15.8  % were pseudophakic and 5.3  % were aphakic. 
The average preoperative IOP was 10.2 ± 4.1 mmHg and 
postoperative IOP was 11.6 ± 3.8 mm Hg.
The average preoperative BCVA was greater than 1.3 
LogMAR (<20/400 Snellen Equivalent). All eyes achieved 
improvement to a final BCVA ranging from 1.3 to 
0.7 LogMAR. Postoperative hypotony was determined in 
15.8 % of the patients. Only one eye developed neovascu-
lar glaucoma (Table 1).
After the first procedure, 63.2  % of eyes needed a 
second surgery, including enlargement of the retinec-
tomy from 180° to 270° (n = 11) or from 270° to 360° 
(n  =  1), silicone oil removal (n  =  10) and standard 
intraocular lens fixation (n =  2). A total of four eyes 
needed a third surgical procedure, including enlarge-
ment of the retinectomy from 270° to 360°. A final 
reattachment was observed in 94.7  % of the patients. 
Regarding extension of the retinectomy, 44.7  % eyes 
underwent retinectomy greater than 270° after the first 
surgery (Table 1).
There was an association between retinectomy exten-
sion and postoperative visual acuity. A total of 87  % 
(n =  33) of the eyes had better or stabilized postopera-
tive VA compared to preoperative VA. Regarding hypo-
tony, there was no association between the hypotony rate 
and retinectomy extension (Tables  2, 3, 4). No patients 
needed a scleral buckle removal.
Discussion
Proliferative vitreoretinopathy remains the primary cause 
of unsuccessful RRD surgery. Relaxing retinectomies 
are mandatory when a complete relief of retinal traction 
is not possible, even after membrane removal. Previous 





 Female 20 52.5
 Male 18 47.5
Lens status
 Phakic 30 78.9
 Pseudophakic 6 15.8
 Aphakic 2 5.3
IOP (mmHg)
 Preoperative 10.2 (±4.1)
 Postoperative 11.6 (±3.8)
Retinectomy extension
 180° 21 55.3
 270° 7 18.4
 360° 10 26.3
Neovascular glaucoma 1 2.6
Postoperative hypotony 6 15.8
Page 3 of 4Mendes et al. Int J Retin Vitr  (2015) 1:17 
studies reported recurrent RD after 180°–360° retinecto-
mies from 17 to 48 %. Our study found a higher rate of 
recurrent RD; however, most of the studies excluded eyes 
with PVR greater than C2 [9, 10].
Patients with severe PVR C3 who undergo retinectomy 
are more likely to develop postoperative PVR because of 
retinal pigment epithelium exposure, proliferation and 
migration of inflammatory cells on the retinal surface [2, 
3]. In our study, all patients were classified as PVR greater 
than C2. This finding may explain the higher reoperation 
rate after the first procedure. However, the final reattach-
ment rate of 94.7 % was greater than reports in the litera-
ture for severe PVR cases [8, 9, 11].
Postoperative hypotony is a common complica-
tion after large retinectomy and previous studies have 
reported a 15–40  % rate in eyes that underwent a 360° 
retinectomy [10–13]. Additionally, Teke et al. [9] reported 
1.7  % phthisical eyes. We report a 15.8  % postoperative 
hypotony rate, but no patients developed phthisis bulbi in 
our study. This finding may be explained by our choice of 
silicone oil as a tamponade. Several authors believe that 
silicone oil may prevent hypotony and phthisis after vit-
rectomy [10–12, 14].
Our study has several limitations. This research is a ret-
rospective study with a small number of patients. Addi-
tionally, we did not compare our patients with a control 
group in which retinectomy was not performed during 
the first surgical procedure. However, to the best of our 
knowledge, there are few studies in the literature evalu-
ating the efficacy of retinectomy in eyes with PVR grade 
C3. Most studies have included PVR grade C1–C2 only 
[8, 9, 11]. A total of 44.7 % of the patients needed a reti-
nectomy greater than 270° since the first surgery; never-
theless, most of them had an improved or stabilized final 
vision compared to preoperative VA. In the literature, 
only a small number of patients achieved ambulatory 
vision after a large retinectomy [10, 11].
Conclusions
Proliferative vitreoretinopathy is still a major cause of 
failure of RRD surgery, and occasionally, multiple pro-
cedures are required when reattachment is not obtained 
[2, 3, 15]. Retinectomy may result in a higher anatomical 
success rate for severe PVR cases by relaxing the short-
ened retina and may not be related to worse results con-
cerning final visual acuity or hypotony.
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